EDGAR Filing Documents for 0000897069-03-000360

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0000897069-03-000360

Filing Date

2003-03-24

Accepted

2003-03-24 16:39:12

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS	irm236.txt	424B3	58919
	Complete submission text file	0000897069-03-000360.txt		60416

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-31310 | Film No.: 03614260
SIC: 2835 In Vitro & In Vivo Diagnostic Substances